Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
eF-Kam study: Kamikihito for anxiety in frail patients
jRCTs041180056Completed
- Sponsor
- Tsumura & Co.
- Start
- Feb 2019
- Countries
- 1
01
Overview
Randomised trial of kamikihito in anxiety disorder, major depressive disorder (MDD) and Fragility (2 arms), sponsored by Tsumura & Co. Primary endpoint: Hospital Anxiety and Depression Scale (HADS). Started Feb 2019; status: completed.
02
Drugs
kamikihito
03
Conditions
anxiety disordermajor depressive disorder (MDD)Fragility
Beyond the preview
Go deeper on jRCTs041180056.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs041180056.